CYTOSORBENTS CORPORATION - COMMON STOCK
0.8194
02-5月-24 15:58:42
15 分の遅延
株式
-0.0213
-2.53%
本日の幅
0.7995 - 0.8760
ISIN
N/A
ソース
NASDAQ
-
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
01 9 2023 16:43:18 提供 Nasdaq GlobeNewswire
-
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
31 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
01 8 2023 16:15:01 提供 Nasdaq GlobeNewswire
-
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
26 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
19 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
11 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
07 7 2023 07:07:00 提供 Nasdaq GlobeNewswire
-
05 6 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents Reports First Quarter 2023 Results
02 5 2023 16:15:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
26 4 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
20 4 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
19 4 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
29 3 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
22 3 2023 08:09:06 提供 Nasdaq GlobeNewswire
-
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
14 3 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
09 3 2023 16:15:00 提供 Nasdaq GlobeNewswire
-
07 3 2023 07:00:00 提供 Nasdaq GlobeNewswire